MicroRNAs and the kidney: coming of age

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 4, 2009, Pages 317-323

  Saal, Samuel ^a   Harvey, Scott J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Diabetic nephropathy; Dicer; nephrotic syndrome; podocyte

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 10A; MICRORNA 10B; MICRORNA 142; MICRORNA 155; MICRORNA 15A; MICRORNA 17 19; MICRORNA 192; MICRORNA 194; MICRORNA 196A; MICRORNA 196B; MICRORNA 200; MICRORNA 200A; MICRORNA 204; MICRORNA 205; MICRORNA 21; MICRORNA 215; MICRORNA 216; MICRORNA 223; MICRORNA 335; MICRORNA 377; MICRORNA 637; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

CELL TRANSFORMATION; DIABETIC NEPHROPATHY; EXOSOME; GLOMERULAR STRUCTURE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY; KIDNEY ALLOGRAFT REJECTION; KIDNEY CANCER; KIDNEY COLLECTING TUBULE; KIDNEY DEVELOPMENT; KIDNEY POLYCYSTIC DISEASE; LOSS OF FUNCTION MUTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION; URINARY TRACT CANCER;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY NEOPLASMS; MICRORNAS;

EID: 67849099709     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32832c9da2     Document Type: Review

References (71)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-854.
2. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75:855-862.
3. Pasquinelli AE, Reinhart BJ, Slack FJ, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408:86-89.
4. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806-811.
5. Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science 2001; 294:853-857.
6. Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatoryroles in Caenorhabditis elegans. Science 2001; 294:858-861.
7. Lee RC, Ambrose V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294:862-864.
8. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11:228-234.
9. Ding XC, Weiler J, Grosshans H. Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends Biotechnol 2009; 27:27-36.
10. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129:1401-1414.
11. Lagos-Quintana M, Rauhut R, Meyer J, et al. New microRNAs from mouse and human. RNA 2003; 9:175-179.
12. Takada S, Berezikov E, Yamashita Y, et al. Mouse microRNA profiles determined with a new and sensitive cloning method. Nucleic Acids Res 2006; 34:e115.
13. Naraba H, Iwai N. Assessment of the microRNA system in salt-sensitive hypertension. Hypertens Res 2005; 28:819-826.
14. Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 2004; 32:e188.
15. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005; 11:241-247.
16. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101:9740-9744.
17. Tian Z, Greene AS, Pietrusz JL, et al. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res 2008; 18:404-411.
18. Ho J, Ng KH, Rosen S, et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 2008; 19:2069-2075. This study and those by Harvey et al. [31] and Shi et al. [36] demonstrate that miRNAs are essential for podocyte structure and function, and suggest a new pathway that may contribute to the pathogenesis of kidney diseases of podocyte origin.
19. Razzaque MS, Naito T, Taguchi T. Proto-oncogene Ets-1 and the kidney. Nephron 2001; 89:1-4.
20. Kobayashi N, Gao SY, Chen J, et al. Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons? Anat Sci Int 2004; 79:1-10.
21. Rastaldi MP, Armelloni S, Berra S, et al. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 2006; 20:976-978.
22. Barbato C, Giorgi C, Catalanotto C, et al. Thinking about RNA? MicroRNAs in the brain. Mamm Genome 2008; 19:541-551.
23. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439:283-289.
24. Kawahara Y, Zinshteyn B, Sethupathy P, et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007; 315:1137-1140.
25. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development. Nat Genet 2003; 35:215-217.
26. Stefani G, Slack FJ. Small noncoding RNAs in animal development. Nat Rev Mol Cell Biol 2008; 9:219-230.
27. Pastorelli LM, Wells S, Fray M, et al. Genetic analyses reveal a requirement for Dicer1 in the mouse urogential tract. Mamm Genome 2009; 20:140-151. This study demonstrates that functional knockout of miRNAs in the renal collecting system causes hydronephrosis.
28. Ho J, Engleka KA, Epstein JA, et al. A requirement for miRNAs in the mesenchyme during early kidney development [abstract]. J Am Soc Nephrol 2007; 18:92A.
29. Wei Q, Bhatt K, Mi QS, et al. Targeted deletion of Dicer in proximal tubular cells protects against ischemic renal injury and renal failure [abstract]. J Am Soc Nephrol 2008; 19:25A.
30. Moeller MJ, Sanden SK, Soofi A, et al. Podocyte-specific expression of Cre recombinase in transgenic mice. Genesis 2003; 35:39-42.
31. Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of Dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 2008; 19:2150-2158. This study and those by Ho et al. [18] and Shi et al. [36] demonstrate that miRNAs are essential for podocyte structure and function, and suggest a new pathway that may contribute to the pathogenesis of kidney diseases of podocyte origin.
32. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15:261-271.
33. Kuhnert F, Mancuso MR, Hampton J, et al. Attribution of vascular phenotypes of the murine Egf17 locus to the microRNA miR-126. Development 2008; 135:3989-3993.
34. Schmidt M, Paes K, De Mazière A, et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007; 134:2913-2923.
35. Osokine I, Hsu R, Loeb GB, et al. Unintentional miRNA ablation is a risk factor in gene knockout studies: a short report. PLoS Genet 2008; 4:e34.
36. Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of Dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008; 19:2159-2169. This study and those by Ho et al. [18] Harvey et al. [31] demonstrate that miRNAs are essential for podocyte structure and function, and suggest a new pathway that may contribute to the pathogenesis of kidney diseases of podocyte origin.
37. Shi S, Yu L, Sun Y, et al. Exploration of the roles for miR-30 family in podocytopathies [abstract]. J Am Soc Nephrol 2008; 19:430A.
38. Hand NJ, Master ZR, Eauclaire SF, et al. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology 2009; 136:1081-1090.
39. Selbach M, Schwanhäusser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455:58-63. This study used a novel proteomic technique, pSILAC, to identify miRNA targets. Results for several miRNAs, including miR-30a, are available online.
40. Smibert P, Lai EC. Lessons from microRNA mutants in worms, flies and mice. Cell Cycle 2008; 7:2500-2508.
41. Agrawal R, Tran U, Wessely O. Expression and functional analysis of miRNAs in kidney development [abstract]. Dev Biol 2008; 319:605.
42. Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science 2005; 309:310-311.
43. Iwai N, Naraba H. Polymorphisms in human premiRNAs. Biochem Biophys Res Commun 2005; 331:1439-1444.
44. Borel C, Antonarakis SE. Functional genetic variation of human miRNAs and phenotypic consequences. Mamm Genome 2008; 19:503-509.
45. Lee SO, Masyuk T, Splinter P, et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 2008; 118:3714-3724.
46. Jing X, Ju W, Shang H, et al. Role of miR-21 in renal injury [abstract]. J Am Soc Nephrol 2008; 19:186A.
47. Shang H, Nitsche E, Jing X, et al. Inhibition of TGF-b signaling by miR-23b [abstract]. J Am Soc Nephrol 2008; 19:143A.
48. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-b-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104:3432-3437.
49. Kato M, Wang L, Wang M, et al. Roles of renal microRNA-216a (miR-216a) in TGF-b signaling and diabetic nephropathy [abstract]. FASEB J 2008; 22:603.4.
50. Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22:4126-4135. This study places miR-377 at the crossroads of pathways promoting sclerosis and metabolic abnormalities in diabetic glomeruli.
51. Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell cycle 2008; 7:2591-2600.
52. Kort EJ, Farber L, Tretiakova M, et al. The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 2008; 68:4034-4038. This study provides the first evidence implicating miRNAs in Wilms' tumor.
53. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10:593-601. This study identified miRNAs that reinforce epithelial differentiation and target genes mediating these effects. Their disruption could promote EMT in kidney disease.
54. Nakada C, Matsuura K, Tsukamoto Y, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008; 216:418-427.
55. Pandey P, Brors B, Srivastava PK, et al. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 2008; 9:624.
56. Dai Y, Sui W, Lan H, et al. Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy. Saudi Med J 2008; 29:1388-1393.
57. Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2008. [Epub ahead of print]
58. Sui W, Dai Y, Huang Y, et al. Microarray analysis of microRNA expression in acute rejection after renal transplantation. Transpl Immunol 2008; 19:81-85.
59. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106:5330-5335. This study showed that miRNA profiling of renal biopsy specimens can predict acute rejection and allograft function. miRNAs expressed both resident kidney cells and infiltrating immune cells may serve as useful biomarkers of allograft status.
60. Kato M, Wang L, Wang M, et al. Functions of kidney-specific microRNAs in TGF-b signaling and diabetic nephropathy [abstract]. J Am Soc Nephrol 2007; 18:198A.
61. Fraser DJ, Phillips AO, Zhang X, et al. Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells. Kidney Int 2008; 73:724-732.
62. Krichevsky AM, Gabriely G. miR-21: a small multifaceted RNA. J Cell Mol Med 2009; 13:39-53.
63. Davis BN, Hilyard AC, Lagna G, et al. SMAD proteins control DROSHA- mediated microRNA maturation. Nature 2008; 454:56-61. This study describes a novel mechanism regulating miRNA expression. SMAD proteins, effectors of the TGF-b1 signaling pathway, interact with the miRNA- processing enzyme Drosha to promote miR-21 maturation.
64. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol 2009; 174:1131-1138.
65. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25:387-392.
66. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007; 282:2130-2134.
67. Melkonyan HS, Feaver WJ, Meyer E, et al. Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci 2008; 1137:73-81.
68. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2007; 101:13368-13373.
69. Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659.
70. Zhou H, Cleary RC, Bogaert YE, et al. Combination of microRNA192 and microRNA27b from urinary exosomes differentiate between renal tubular damage and glomerular injury [abstract]. J Am Soc Nephrol 2008; 19:672A.
71. Krutzfeldt J, Rajwesky N, Braich R, et al. Silencing of microRNAs in vivo with "antagomirs". Nature 2005; 438:685-689.